Clinical Trial Update: Modulation of Anaerobic Gut Bacteria of Arsenicosis Patients by Probiotics [NA]

View source ↗

Summary

A completed clinical trial investigated whether probiotics can modulate anaerobic gut bacteria in patients with chronic arsenic poisoning (arsenicosis).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arsenic Poisoning

Drugs mentioned

• Probiotic formulation used in NCT01726426 (probiotic)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Chronic Arsenic Poisoning | NA | Status: COMPLETED